Dexetra
Dexetra is a Private Indian company incorporated in 2010 and based in Kerala, India. Dexetra operates in IT & Software (NIC 72200) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
DEXETRA - App Development Studio. This company is not active anymore. Raised a total funding of $1M over 2 rounds from 4 investors.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Dexetra.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +34d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Dexetra.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 494433520 | ICICI Bank Ltd(Bank) | ₹23.23 Cr | 27 Jan 2020 | Satisfied |
| 915984180 | Axis Bank Ltd(Bank) | ₹3.13 Cr | 19 Sep 2021 | Open |
| 792229102 | ICICI Bank Ltd(Bank) | ₹59.67 L | 27 Jan 2020 | Satisfied |
| 104824062 | Kotak Mahindra Bank Ltd(Bank) | ₹19.99 Cr | 27 Jan 2020 | Open |
| 645161335 | HDFC Bank Ltd(Bank) | ₹9.49 Cr | 19 Sep 2022 | Open |
Charge IDs, lenders & amounts for Dexetra.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹77.58 Cr | ₹6.86 Cr | ₹50.69 Cr | ₹114.82 Cr | 24 |
| FY2023-24 | ₹65.91 Cr | ₹3.84 Cr | ₹70.56 Cr | ₹109.34 Cr | 113 |
| FY2022-23 | ₹47.87 Cr | ₹4.24 Cr | ₹55.40 Cr | ₹80.45 Cr | 177 |
| FY2021-22 | ₹45.29 Cr | ₹4.27 Cr | ₹20.56 Cr | ₹60.43 Cr | 81 |
Audited financials & ratios for Dexetra.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹77.58 Cr | ₹65.91 Cr | ₹47.87 Cr | ₹45.29 Cr |
| Other income | ₹58.92 L | ₹2.18 Cr | ₹62.09 L | ₹44.08 L |
| Total income | ₹78.17 Cr | ₹68.08 Cr | ₹48.49 Cr | ₹45.73 Cr |
| Total expenses | ₹69.38 Cr | ₹63.16 Cr | ₹43.06 Cr | ₹40.26 Cr |
| Profit before tax | ₹8.92 Cr | ₹5.00 Cr | ₹5.51 Cr | ₹5.56 Cr |
| Profit / (Loss) after tax | ₹6.86 Cr | ₹3.84 Cr | ₹4.24 Cr | ₹4.27 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹50.69 Cr | ₹70.56 Cr | ₹55.40 Cr | ₹20.56 Cr |
| Borrowings | ₹19.07 Cr | ₹13.09 Cr | ₹11.92 Cr | ₹10.64 Cr |
| Current liabilities | ₹31.69 Cr | ₹15.18 Cr | ₹10.81 Cr | ₹15.08 Cr |
| Total liabilities | ₹64.13 Cr | ₹38.78 Cr | ₹25.06 Cr | ₹39.87 Cr |
| Current assets | ₹59.25 Cr | ₹61.00 Cr | ₹28.59 Cr | ₹35.18 Cr |
| Cash & equivalents | ₹7.85 Cr | ₹13.51 Cr | ₹4.46 Cr | ₹9.71 Cr |
| Total assets | ₹114.82 Cr | ₹109.34 Cr | ₹80.45 Cr | ₹60.43 Cr |
| Employees | 24 | 113 | 177 | 81 |
Audited financials & ratios for Dexetra.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹77.58 Cr | +33.4% | +7.6% | +15.3% |
| Profit after Tax | ₹6.86 Cr | +27.5% | +23.3% | +15.7% |
| Net Worth | ₹50.69 Cr | +7.7% | -4.9% | +19.9% |
| Employees | 24 | +30.7% | +4.5% | +17.7% |
Audited financials & ratios for Dexetra.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹77.58 Cr | ₹6.86 Cr | +8.85% | +25.40% | +13.54% | +5.98% | 0.38 | ₹3.23 Cr |
| FY2023-24 | ₹65.91 Cr | ₹3.84 Cr | +5.83% | +27.33% | +5.45% | +3.51% | 0.19 | ₹58.33 L |
| FY2022-23 | ₹47.87 Cr | ₹4.24 Cr | +8.86% | +27.85% | +7.66% | +5.27% | 0.22 | ₹27.04 L |
| FY2021-22 | ₹45.29 Cr | ₹4.27 Cr | +9.44% | +18.40% | +20.79% | +7.07% | 0.52 | ₹55.91 L |
Audited financials & ratios for Dexetra.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 21,11,018 | 82.96% |
| Institutional Investors | 2 | 1,72,559 | 6.78% |
| Public & Others | 28 | 2,61,033 | 10.26% |
Promoter, institutional & public holding for Dexetra.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
26 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.